Sign inJoin waitlistJoin the waitlist

John Rose

Chief Resident, PGY-4

Credentials: · ·

History

Neurology
Univ of Utah Sch of Med
PGY-42023–Present
2023–Present
Child and Adolescent Psychiatry
2027–2029
National Institute of Health
1984–1985
National Institute of Health
1979–1980
Neurology
University of Maryland School of Medicine
1976–1979
Internal Medicine
University of Maryland Medical Center Midtown Campus
1975–1976
University of Maryland School of Medicine
1971–1975
Johns Hopkins University
1967–1971

Research

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The…
Neurology · 1995 · 1,538 citations
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple…
Neurology · 1998 · 375 citations
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
The Lancet Neurology · 2010 · 237 citations

EW
Emmanuelle Waubant
54 papers
Tanuja Chitnis
54 papers
MG
Mark Gorman
53 papers
LB
Leslie Benson
52 papers
MR
Moses Rodriguez
51 papers
Lauren Krupp
50 papers
Timothy Lotze
50 papers
Soe Mar
49 papers
Jennifer Graves
47 papers
Gregory Aaen
46 papers
Teri Schreiner
46 papers
Jan-Mendelt Tillema
44 papers